ArticleThe journal of gene medicine2023

Evaluation of CRISPR/Cas9 exon-skipping vector for choroideremia using human induced pluripotent stem cell-derived RPE.

Toshiro Iwagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.